Proven track record of success across 100+ biopharmas

As Immuneering advanced Atebimetinib into a pivotal Phase 3 pancreatic cancer trial, its finance team needed a scalable way to forecast and close R&D expenses.

As Associate Director of Clinical Vendor and Program Management, Daniel Gay-Betton oversees 60 site investigators across one phase 3 and one phase 4 clinical trials…

Shifting from pre-clinical to clinical, and focused on public market preparedness, PMV recognized the need to re-think study-level financial processes.

Incendia's Controller sat down with the Auxilius team to discuss how they use Auxilius to streamline clinical trial accrual workflows…

As Invivyd scaled its clinical operations and approached a critical commercial launch, the company faced significant challenges in managing its clinical trial financials…